International Business Machines Corporation (IBM) was awarded a $7,081,492.15 delivery order against the Center for Biologics Evaluation and Research (CBER) Biologics Effectiveness and Safety (BEST) Initiative master indefinite delivery/indefinite quantity contract by the Department of Health and Human Services Food and Drug Administration. The delivery order is for the development of new and innovative methods for automated reporting to support CBER-regulated biologics and has a completion date...
This federal contract award was issued by the Food and Drug Administration (FDA) to International Business Machines Corporation (IBM) to support the Center for Biologics Evaluation and Research (CBER) Biologics Effectiveness and Safety (BEST) Initiative. The $8,234,421.12 delivery order contract will develop new and innovative methods for automated reporting for CBER-regulated biologics. The contract is a Time and Materials (T&M) type and does not have a set-aside designation. IBM will be...
This federal contract was awarded by the Department of Health and Human Services Food and Drug Administration to the International Business Machines Corporation (IBM) on September 24, 2019. The $5,622,942.08 time and materials contract is a delivery order under the BEST Initiative - Data Tools and Infrastructure for Surveillance of Biologics master IDIQ contract vehicle. The objective is for IBM to conduct surveillance activities to assess the safety and effectiveness of biologics. This work...
The Department of Health and Human Services Food and Drug Administration (HHS FDA) awarded a $13.2 million delivery order contract to International Business Machines Corporation (IBM) under the Biologics Effectiveness and Safety (BEST) Initiative - Data Tools and Infrastructure for Surveillance of Biologics indefinite-delivery/indefinite-quantity (IDIQ) contract vehicle. The contract calls for IBM to provide data, tools, and infrastructure to support HHS FDA's BEST Initiative for surveillance of...
The Department of Health and Human Services Food and Drug Administration awarded a $2,611,999.89 Delivery Order contract to International Business Machines Corporation (IBM) on June 19, 2018 for CDER Business Informatics Governance & Process Implementation services. This contract, which did not have a set-aside designation, had a completion date of September 30, 2019. As a major federal IT services provider, IBM has supported various government agencies through prime and subcontract awards...
The Department of Health and Human Services Food and Drug Administration awarded a $465,931.45 Delivery Order contract to International Business Machines Corporation (IBM) for Pharmaceutical Quality/Chemistry, Manufacturing, and Control (PQ/CMC) Data Standards. This is not a set-aside contract. As a major federal IT services provider, IBM supports critical systems and operations for civilian agencies like the FDA. The contract has a completion date of September 28, 2018 and is a Labor Hours...
This $7,464,141.78 contract was awarded by the Food and Drug Administration (FDA) to International Business Machines Corporation (IBM) to adapt to evolving HL7 standards and ensure continuity of operations as well as enabling enhancements at the FDA. The contract is a Blanket Purchase Agreement (BPA) call and utilizes a labor hours pricing type. As the prime contractor, IBM has engaged several subcontractors, including Accenture Federal Services, Eclaro International, Eight Eleven Group, Medstar...
This is a $636,006.69 delivery order contract awarded by the Food and Drug Administration (FDA) to International Business Machines Corporation (IBM) on August 17, 2015. The contract is for labor hours pricing and has an ultimate completion date of December 31, 2016. The contract is not set aside. IBM, the prime contractor, is a major global technology company that provides a wide range of hardware, software, cloud computing, artificial intelligence, and consulting services to the U.S. federal...
This $14,672,586.36 firm fixed-price federal contract was awarded by the Food and Drug Administration (FDA) to International Business Machines Corporation (IBM) on September 3, 2024. The contract is a Blanket Purchase Agreement (BPA) Call under the Regulatory Review Support Services vehicle and is focused on "Improvements in Pharmaceutical Quality/Chemistry, Manufacturing, and Control (PQ/CMC) Data Standards for Regulatory Submissions, Review and Analysis." The contract has an ultimate...
The Department of Health and Human Services Food and Drug Administration awarded a $318,390.27 firm fixed price Blanket Purchase Agreement (BPA) call to International Business Machines Corporation (IBM) for the ORACLE PROJECT MODULE, with a period of performance ending on July 10, 2018. This contract was not set aside. IBM is a major federal information technology contractor that provides a wide range of products and services to civilian and defense agencies, including critical systems and...